January 18, 2000Spectrum Laboratory
Products Recalls Dihydroergotamine Mesylate Powder
Gardena, CA (SafetyAlerts) - The Food and Drug
Administration (FDA) today reported that Spectrum Laboratory Products, Inc. is recalling
Dihydroergotamine Mesylate Powder because of possible cross contamination with cefadroxil.
The recalled prescription bulk active
ingredient was distributed in 250 mg, 1 g and 5 g containers and can be identified by the
lot numbers NL0465, OC0650 or OG0622. The expiration date for all lots is EXP
According to FDA, the product was
distributed in California, Colorado, Georgia, North Carolina, Oregon, Rhode Island, Texas
This ongoing Class II recall
was initiated by Spectrum Laboratory by letter on December 10, 1999, followed by telephone
on or about December 27, 1999. This is the first public notice issued by the FDA.
Questions concerning this recall may
be directed to the FDA at 1-888-INFO-FDA.
FDA Recall #D-201-0
Safety Alerts compiles
comprehensive safety recall information for the United States. SafeMail is a free email
service to warn consumers of faulty products and contaminated foods. For complete
information regarding current recalls, past recalls and timely product warning
notification visit: www.safetyalerts.com.